4.7 Article

Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study

Renin Chang et al.

Summary: This retrospective cohort study reveals that there is a significant association between COVID-19 and the risk of autoimmune diseases. However, further research is needed to replicate these findings in an independent dataset and understand the underlying mechanisms.

ECLINICALMEDICINE (2023)

Article Rheumatology

Rheumatoid factor autoantibody repertoire profiling reveals distinct binding epitopes in health and autoimmunity

Nienke Oskam et al.

Summary: This study identified specific epitopes associated with rheumatoid arthritis and healthy individuals. The study also found that IgM-RFs have the ability to activate complement or inhibit IgG-mediated complement activation, depending on the epitopes they bind to. These results demonstrate the need to redefine 'RF' into pathological and physiological autoantibody subtypes.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study

Falko Tesch et al.

Summary: In this large cohort study, we found that patients with prior COVID-19 infection have a higher risk of developing autoimmune diseases compared to those without COVID-19.

CLINICAL RHEUMATOLOGY (2023)

Article Immunology

Discriminating promiscuous from target-specific autoantibodies in COVID-19

Mikhail Lebedin et al.

Summary: Diverse autoantibodies in COVID-19 have unclear functional implications. ACE2 is one of the targets of autoantibodies. Elevated levels of sACE2 and anti-ACE2 IgG were observed in critically ill patients, but they were poorly correlated. IgGs recognizing ACE2, IFN alpha 2, and CD26 correlated strongly in severe COVID-19, with some showing polyreactivity. Promiscuous autoantibodies did not impair ACE2 and IFN alpha 2 activity, while specific anti-IFN alpha 2 IgG compromised cytokine function.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Review Immunology

Transforming mutations in the development of pathogenic B cell clones and autoantibodies*

Joanne H. Reed

Summary: Autoimmune diseases are characterized by the presence of serum autoantibodies, which can be pathogenic and cause severe manifestations and organ injury. The development of these autoantibodies is driven by various genetic and environmental factors, but the factors behind the development of pathogenic autoantibodies are not well understood. Recent advancements in single-cell technology have allowed for the analysis of rare B cell clones producing pathogenic autoantibodies, revealing genetic events and mutations that disrupt antibody quality control mechanisms and decrease autoantibody solubility. Understanding the molecular characteristics and tolerance checkpoints involved in the formation of these pathogenic autoantibodies will improve prognostication, enabling early treatment to prevent organ damage and B cell malignancy.

IMMUNOLOGICAL REVIEWS (2022)

Article Immunology

Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome

Yeny Acosta-Ampudia et al.

Summary: Post-COVID syndrome is characterized by the persistence of latent autoimmunity up to 11 months after recovery, accompanied by a persistent proinflammatory state and altered effector phenotype. The need to evaluate the role of immunomodulation in the treatment of PCS is suggested.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Rheumatology

Rheumatoid Factor and Anti-Modified Protein Antibody Reactivities Converge on IgG Epitopes

Aisha M. Mergaert et al.

ARTHRITIS & RHEUMATOLOGY (2022)

Editorial Material Medicine, Research & Experimental

Autoimmunity is a hallmark of post-COVID syndrome

Manuel Rojas et al.

Summary: Autoimmunity is a characteristic of post-COVID syndrome (PCS), and it is correlated with the humoral response to SARS-CoV-2.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Medicine, General & Internal

New-onset Seropositive Rheumatoid Arthritis Following COVID-19 Vaccination in a Patient with Seronegative Status

Haruka Yonezawa et al.

Summary: Although COVID-19 mRNA vaccines have been effective in reducing the severity of the disease, some patients may experience severe adverse reactions and newly onset autoimmune phenomena, such as rheumatoid arthritis. This report presents a case of new-onset seropositive rheumatoid arthritis following COVID-19 mRNA vaccination.

INTERNAL MEDICINE (2022)

Article Multidisciplinary Sciences

Dysregulated naive B cells and de novo autoreactivity in severe COVID-19

Matthew C. Woodruff et al.

Summary: This study demonstrates the origins, breadth, and resolution of autoreactivity in severe COVID-19, with implications for early intervention and the treatment of patients with post-COVID sequelae.

NATURE (2022)

Article Medicine, Research & Experimental

COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?

Simona Pascolini et al.

Summary: Auto-antibodies are frequently detected in patients with COVID-19, potentially indicating a role in immune dysregulation and a link to poor prognosis.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Article Biochemical Research Methods

MixTwice: large-scale hypothesis testing for peptide arrays by variance mixing

Zihao Zheng et al.

Summary: Peptide microarrays are a powerful tool in immunoproteomics, but face challenges with high dimensionality and small sample sizes in experiments. The MixTwice tool addresses limitations in reproducibility and power of current methods by computing local FDR statistics and local false sign rate statistics, effectively estimating generative parameters and identifying non-null peptides. Numerical experiments demonstrate its accuracy and reproducibility in identifying meaningful peptide markers in different signal strengths.

BIOINFORMATICS (2021)

Article Biochemistry & Molecular Biology

The landscape of antibody binding in SARS-CoV-2 infection

Anna S. Heffron et al.

Summary: Research shows that SARS-CoV-2 infection triggers robust antibody responses throughout the proteome, with M protein exhibiting excellent diagnostic accuracy. Antibodies also bind to homologous peptide sequences in other known human coronaviruses, and illness severity correlates with increased reactivity to specific epitopes.

PLOS BIOLOGY (2021)

Article Immunology

Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients

Baolin Liao et al.

Summary: Characterizing the serologic features of asymptomatic SARS-CoV-2 infection is crucial for diagnostics and control. This study found that asymptomatic infections exhibit weaker overall antibody responses, primarily inducing IgG antibody responses. Anti-S2-IgG shows better sensitivity in identifying asymptomatic infections early after infection compared to anti-RBD-IgG.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19

Chen Xu et al.

Summary: The study found that 20.16% of COVID-19 patients tested positive for rheumatoid-associated autoantibodies, with IgM-RF predominantly present in critically ill patients and IgA-RF mainly present in mild patients. The antibodies peaked in the later phase of the disease and lasted for a longer time.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Article Immunology

Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19

Juan-Manuel Anaya et al.

Summary: This study evaluated the presence of autoimmune responses in COVID-19 patients, revealing a latent autoimmunity that could influence disease severity, particularly with high frequencies of RF, IgM anti-beta 2GP1 antibodies, and ANAs potentially leading to more severe illness.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)

Editorial Material Rheumatology

New Relationships for Old Autoantibodies in Rheumatoid Arthritis

Miriam A. Shelef

ARTHRITIS & RHEUMATOLOGY (2019)

Article Multidisciplinary Sciences

Immunoglobulin G structure and rheumatoid factor epitopes

Sheila Lefoli Maibom-Thomsen et al.

PLOS ONE (2019)

Article Rheumatology

Respiratory viral infections and the risk of rheumatoid arthritis

Young Bin Joo et al.

ARTHRITIS RESEARCH & THERAPY (2019)

Editorial Material Rheumatology

Defective Early B Cell Tolerance Checkpoints in Sjogren's Syndrome Patients

Eric Meffre

ARTHRITIS & RHEUMATOLOGY (2017)

Article Biochemistry & Molecular Biology

The MEME Suite

Timothy L. Bailey et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Biotechnology & Applied Microbiology

Rheumatoid Factors: Clinical Applications

Francesca Ingegnoli et al.

DISEASE MARKERS (2013)

Review Allergy

Molecular Mimicry as a Mechanism of Autoimmune Disease

Matthew F. Cusick et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)

Article Immunology

Antigen-Driven Induction of Polyreactive IgM during Intracellular Bacterial Infection

Derek D. Jones et al.

JOURNAL OF IMMUNOLOGY (2012)

Article Dentistry, Oral Surgery & Medicine

Rheumatoid factor from periodontitis patients cross-reacts with epitopes on oral bacteria

J The et al.

ORAL DISEASES (2010)

Article Immunology

Defective B cell tolerance checkpoints in systemic lupus erythematosus

S Yurasov et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)